Does the primary treatment sequence affect post‐relapse survival in recurrent epithelial ovarian cancer? A real‐world multicentre retrospective study-Reference-Cited by-全球学者库

Does the primary treatment sequence affect post‐relapse survival in recurrent epithelial ovarian cancer? A real‐world multicentre retrospective study

Published:2022-11 Issue:S2 Volume:129 Page:70-78
ISSN:1470-0328
Container-title:BJOG: An International Journal of Obstetrics & Gynaecology
language:en
Short-container-title:BJOG

Author:

Liu Xingyu¹²,Zhao Yingjun¹²,Jiao Xiaofei¹²,Yu Yang¹²,Li Ruyuan³,Zeng Shaoqing¹²,Chi Jianhua¹²,Ma Guanchen¹²,Huo Yabing¹²,Li Ming¹²,Peng Zikun¹²,Liu Jiahao¹²,Zhou Qi⁴⁵,Zou Dongling⁴⁵,Wang Li⁶,Li Qingshui⁷,Wang Jing⁸⁹,Yao Shuzhong¹⁰,Chen Youguo¹¹,Ma Ding¹²,Hu Ting¹²,Gao Qinglei¹²^ORCID

Affiliation:

1. Department of Gynecological Oncology Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology Wuhan China

2. National Clinical Research Center for Obstetrics and Gynecology, Cancer Biology Research Center (Key Laboratory of the Ministry of Education) Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology Wuhan China

3. National Cancer Center/Cancer Hospital Chinese Academy of Medical Sciences and Peking Union Medical College Beijing China

4. Department of Gynecologic Oncology Chongqing University Cancer Hospital Chongqing China

5. Chongqing Key Laboratory of Translational Research for Cancer Metastasis and Individualized Treatment Chongqing University Cancer Hospital Chongqing China

6. Department of Cancer Biology Immunotherapy The Affiliated Cancer Hospital of Zhengzhou University and Henan Cancer Hospital Zhengzhou, Henan China

7. Department of Gynecologic Oncology Shandong Cancer Hospital and Institute Jinan, Shandong China

8. Hunan Clinical Research Center in Gynecologic Cancer Hunan Cancer Hospital and The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University Changsha, Hunan China

9. Department of Gynecologic Cancer Hunan Cancer Hospital and The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University Changsha, Hunan China

10. Department of Obstetrics and Gynecology The First Affiliated Hospital, Sun Yat‐sen University Guangzhou, Guangdong China

11. Department of Gynecology & Obstetrics The First Affiliated Hospital of Soochow University Suzhou, Jiangsu Province China

Funder

National Natural Science Foundation of China

Chinese Society of Clinical Oncology

Publisher

Wiley

Subject

Obstetrics and Gynecology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/1471-0528.17329

Reference39 articles.

1. Primary chemotherapy versus primary surgery for newly diagnosed advanced ovarian cancer (CHORUS): an open-label, randomised, controlled, non-inferiority trial

2. Intervention debulking surgery in advanced epithelial ovarian cancer;Redman CW;Br J Obstet Gynaecol,1994

3. Secondary Surgical Cytoreduction for Advanced Ovarian Carcinoma

4. The effect of debulking surgery after induction chemotherapy on the prognosis in advanced epithelial ovarian cancer. Gynecological cancer cooperative Group of the European Organization for research and treatment of cancer;Burg ME;N Engl J Med,1995

5. Neoadjuvant Chemotherapy or Primary Surgery in Stage IIIC or IV Ovarian Cancer

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prognostic Significance of Preoperative Inflammation Markers on the Long-Term Outcomes in Peritoneal Carcinomatosis from Ovarian Cancer;Cancers;2024-01-05